Skip to main content
Premium Trial:

Request an Annual Quote

Modest Gain This Week for the BCW Index

The BCW Index rose .9 percent for the week ended Tuesday, outgaining the Nasdaq, which rose .2 percent for the tracking period, and the Nasdaq Biotech Index, which climbed .7 percent. The Dow Jones Industrial Average declined .3 percent.

Shares of Bruker BioSciences rose 4.3 percent to lead the Index, while Harvard Bioscience continued its recent ascent with a 4 percent gain for the week. Only four firms in the Index posted declines this week, led by a 1.7 percent dip for Bio-Rad Laboratories.

BioCommerce Week Index of Diversified Molecular Biology Tool Companies
Company
Ticker
Current Price
(Dec. 13, 2005)
Last Price
(Dec. 6, 2005)
% change
Agilent
A
35.98
34.94
2.98
Applied Biosystems
ABI
27.57
27.34
0.84
Beckman
BEC
57.22
55.73
2.67
Bio-Rad
BIO
60.14
61.19
-1.72
Bruker
BRKR
5.4
5.18
4.25
Fisher Scientific
FSH
64.52
63.34
1.86
GE
GE
35.47
35.8
-0.92
Harvard Bio
HBIO
4.69
4.51
3.99
Invitrogen
IVGN
66.56
65.6
1.46
Molecular Devices
MDCC
28.21
28.02
0.68
PerkinElmer
PKI
23.4
23.06
1.47
Qiagen
QGEN
11.67
11.36
2.73
Sigma
SIAL
65.2
65.41
-0.32
Stratagene
STGN
10.69
10.49
1.91
Thermo
TMO
30.76
31.25
-1.57
Waters
WAT
39.29
38.55
1.92
BCW Index Average
35.42
35.11
0.89
The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more